2009•中国综合临床Requires access

Multivariate analysis of prognostic factors in 112 patients with small cell lung cancer

Ji-rong Cheng, Shuqin Wang, Zumureti

Open publisher page 0 citations

Abstract

Objective To analyze the prognostic factors in patients with small cell lung cancer(SCLC). Methods Clinical data of 112 patients with small cell lung cancer diagnosed by histopathology or Cytology were col-lected. The relationship between gender, age, stage, the level of Hemoglobin (Hb) and lactate dehydrogenase (LDH), the efficacy of first -line chemotherapy, radiotherapy and operation with the survival time was analyzed. Ka-plan-Meler, COX multivariate proportional hazards model and Log-rank test were used to analyze the prognostic fac-tors. Results 1, 2, and3 year survival rate was71.4%, 38.4% and 14.3% respectively,80.0%,47.1% and 17.1% in limited disease (LD) patients,57.1%,23.8% and 9.5% in extensive disease (ED) patients. Median survival time (MST) of all the patients was 22 months, 24 months in LD, and 16 months in ED. Univariate analysis indicated that stage, Hb, LDH, the efficacy of first-line chemotherapy, radiotherapy and operation significantly in-fluenced survival in SCLC. Multivariate analysis suggested that stage, the efficacy of first-line chemotherapy, radio-therapy and operation were the independent prognositic factors of survival (relative risk degree=0.687, 0.635, 0.412, 0.203). Conclusion Stage, efficacy of first-line chemotherapy, radiotherapy and operation are the impor-tant prognostic factors for patients with SCLC. Key words: Small cell lung cancer;  Prognosis;  Multivariate analysis

About this research paper

What this paper is about

Objective To analyze the prognostic factors in patients with small cell lung cancer(SCLC). Methods Clinical data of 112 patients with small cell lung cancer diagnosed by histopathology or Cytology were col-lected. The relationship between gender, age, stage, the level of Hemoglobin (Hb) and lactate dehydrogenase (LDH), the efficacy of first -line chemotherapy, radiotherapy and operation with the survival time was analyzed. Ka-plan-Meler, COX multivariate proportional hazards model and Log-rank test were used to analyze the prognostic fac-tors. Results 1, 2, and3 year survival rate was71.4%, 38.4% and 14.3% respectively,80.0%,47.1% and 17.1% in limited disease (LD) patients,57.1%,23.8% and 9.5% in extensive disease (ED) patients. Median survival time (MST) of all the patients was 22 months, 24 months in LD, and 16 months in ED. Univariate analysis indicated that stage, Hb, LDH, the efficacy of first-line chemotherapy, radiotherapy and operation significantly in-fluenced survival in SCLC. Multivariate analysis suggested that stage, the efficacy of first-line chemotherapy, radio-therapy and operation were the independent prognositic factors of survival (relative risk degree=0.687, 0.635, 0.412, 0.203). Conclusion Stage, efficacy of first-line chemotherapy, radiotherapy and operation are the impor-tant prognostic factors for patients with SCLC. Key words: Small cell lung cancer;  Prognosis;  Multivariate analysis

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To analyze the prognostic factors in patients with small cell lung cancer(SCLC). Methods Clinical data of 112 patients with small cell lung cancer diagnosed by histopathology or Cytology were col-lected. The relationship between gender, age, stage, the level of Hemoglobin (Hb) and lactate dehydrogenase (LDH), the efficacy of first -line chemotherapy, radiotherapy and operation with the survival time was analyzed. Ka-plan-Meler, COX multivariate proportional hazards model and Log-rank test were used to analyze the prognostic fac-tors. Results 1, 2, and3 year survival rate was71.4%, 38.4% and 14.3% respectively,80.0%,47.1% and 17.1% in limited disease (LD) patients,57.1%,23.8% and 9.5% in extensive disease (ED) patients. Median survival time (MST) of all the patients was 22 months, 24 months in LD, and 16 months in ED. Univariate analysis indicated that stage, Hb, LDH, the efficacy of first-line chemotherapy, radiotherapy and operation significantly in-fluenced survival in SCLC. Multivariate analysis suggested that stage, the efficacy of first-line chemotherapy, radio-therapy and operation were the independent prognositic factors of survival (relative risk degree=0.687, 0.635, 0.412, 0.203). Conclusion Stage, efficacy of first-line chemotherapy, radiotherapy and operation are the impor-tant prognostic factors for patients with SCLC. Key words: Small cell lung cancer;  Prognosis;  Multivariate analysis

Key concepts: Internal medicine, Medicine, Radiation therapy, Multivariate analysis, Chemotherapy, Lung cancer, Proportional hazards model, Stage (stratigraphy)

Back to paper searchBrowse research topicsOriginal source
Multivariate analysis of prognostic factors in 112 patients with small cell lung cancer — Research Paper | ScholarLens